Krzysztof Palczewski, Ph.D is a Polish biochemist.

His MS and PhD are from the University of Wroclaw, Poland, working with Dr. M. Kochman. His early posts were at the University of Florida and the Oregon Health Sciences University. Palczewski completed much of his pivotal research at the University of Washington and moved to become the Chair and John H. Hord professor of Pharmacology at Case Western Reserve University in 2005.^[1]

He is the founder of two drug discovery companies, Polygenix and Retinagenix.^[2]

Contents 1 Research Interests 2 References 2.1 Notes 2.2 Bibliography 3 External links

[edit] Research Interests

Palczewski's research interest lie in mapping the Visual Transduction System. His work with determining the crystal structure of rhodopsin has given new insight into the function of G protein receptors. This work has led to revolutionary advances in understanding hereditary blindness and can slow retinal degeneration in adults.

[edit] References

[edit] Notes

[edit] Bibliography

• Vertebrate Phototransduction and the Visual Cycle, Krzysztof Palczewski, Academic Press (2000), ISBN 0121822176

[edit] External links

• Department of Pharmacology, Case Western Reserve University
• Case Western Reserve's new medical researchers pump millions into Northeast Ohio economy
• Interview with Dr. Palczewski